infections

Dietary protein could influence cholera infection, mouse study shows

Dietary protein influences V. cholerae growth, metabolism, virulence, and competition with gut microbes.

Antibiotic-producing gut microbes might raise infection risk

Lantibiotic-producing gut bacteria can prolong gut imbalance and increase susceptibility to dangerous infections after antibiotics.

Microbiome testing for post-infectious IBS: a pilot “microbe-informed” approach presented in Brussels

William Fusco, gastroenterologist at Policlinico Universitario Agostino Gemelli, highlighted a recently published pilot study on post-infectious irritable bowel syndrome (IBS) framed within microbial precision medicine and biomarker-driven care.

Gut microbiome–immune system crosstalk: from homeostasis to strain-level opportunities

Three infant-derived strains isolated and developed by Coree srl that are potentially interesting for immune support.

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.

Insights into Indigenous skin microbiotas offer clues to fungal infection

The findings of a recent study highlight the importance of understanding skin microbiotas to manage long-term fungal infections in Indigenous communities.

Antibiotics can weaken vaccine response by disrupting gut bacteria

A healthy, diverse gut microbiota is important for mounting strong and lasting immune responses to vaccination.

Diet shapes gut microbiota to protect mice against C. difficile 

A recent study highlights the potential for dietary interventions in treating C. difficile infection and inflammatory conditions such as inflammatory bowel disease.

Clinically tested probiotics for common colds management designed by SynBalance

A new scientific publication on the beneficial effect of probiotics on cold symptoms relief, immune response enhancement, and quality of life in healthy adults during winter seasons.

How C. difficile uses unique enzyme to survive in the gut

Targeting TudS could be a potential therapeutic approach for treating C. difficile infections.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top